
FDA Reviews Twice-Yearly HIV Prevention Drug by Gilead Sciences
Trevor Sandoval•
The U.S. Food and Drug Administration (FDA) has officially accepted Gilead Sciences’ New Drug Application (NDA) for lenacapavir, an innovative injectable treatment designed for the prevention of HIV. This drug…














